Efficacy and safety of metoprolol in the treatment of doxorubicin-induced cardiomyopathy in pediatric patients
- 31 January 1995
- journal article
- case report
- Published by Elsevier in American Heart Journal
- Vol. 129 (1) , 197-199
- https://doi.org/10.1016/0002-8703(95)90061-6
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agentsThe American Journal of Cardiology, 1993
- Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in ChildhoodNew England Journal of Medicine, 1991
- Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy.Circulation, 1989
- Reversibility of Severe Left Ventricular Dysfunction Due to Doxorubicin CardiotoxicityAnnals of Internal Medicine, 1987
- Congestive heart failure due to adriamycin cardiotoxicity: Its natural history in childrenCancer, 1981